PT Indofarma Tbk (IDX:INAF)

Revenue by Segment

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Devices & Others	71.75B	104.22B	181.53B	424.22B	802.10B
Medical Devices & Others Growth	-31.16%	-42.59%	-57.21%	-47.11%	-5.60%
Medicine	79.80B	106.16B	342.07B	556.15B	2.10T
Medicine Growth	-24.83%	-68.97%	-38.49%	-73.52%	142.52%
Total	151.55B	210.38B	523.60B	980.37B	2.90T
Total Growth	-27.96%	-59.82%	-46.59%	-66.22%	69.15%

Revenue by Geography

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Indonesia	134.90B	195.51B	501.66B	965.95B	2.90T
Indonesia Growth	-31.00%	-61.03%	-48.07%	-66.63%	70.58%
Export	16.65B	14.87B	21.94B	14.42B	6.89B
Export Growth	11.93%	-32.20%	52.13%	109.22%	-62.40%
Total	151.55B	210.38B	523.60B	980.37B	2.90T
Total Growth	-27.96%	-59.82%	-46.59%	-66.22%	69.15%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 21, 2026

Data Sources Report a data error